Please use this identifier to cite or link to this item: https://doi.org/10.1111/all.14838
Title: Management of anaphylaxis due to COVID-19 vaccines in the elderly
Authors: Bousquet, J
Agache, I
Blain, H
Jutel, M
Ventura, MT
Worm, M
Del Giacco, S
Benetos, A
Bilo, BM
Czarlewski, W
Abdul Latiff, AH
Al-Ahmad, M
Angier, E
Annesi-Maesano, I
Atanaskovic-Markovic, M
Bachert, C
Barbaud, A
Bedbrook, A
Bennoor, KS
Berghea, EC
Bindslev-Jensen, C
Bonini, S
Bosnic-Anticevich, S
Brockow, K
Brussino, L
Camargos, P
Canonica, GW
Cardona, V
Carreiro-Martins, P
Carriazo, A
Casale, T
Caubet, JC
Cecchi, L
Cherubini, A
Christoff, G
Chu, DK
Cruz, AA
Dokic, D
De-Yun Wang 
El-Gamal, Y
Ebisawa, M
Eberlein, B
Farrell, J
Fernandez-Rivas, M
Fokkens, WJ
Fonseca, JA
Gao, Y
Gavazzi, G
Gawlik, R
Gelincik, A
Gemicioğlu, B
Gotua, M
Guérin, O
Haahtela, T
Hoffmann-Sommergruber, K
Hoffmann, HJ
Hofmann, M
Hrubisko, M
Illario, M
Irani, C
Ispayeva, Z
Ivancevich, JC
Julge, K
Kaidashev, I
Khaitov, M
Knol, E
Kraxner, H
Kuna, P
Kvedariene, V
Lauerma, A
Le, LTT
Le Moing, V
Levin, M
Louis, R
Lourenco, O
Mahler, V
Martin, FC
Matucci, A
Milenkovic, B
Miot, S
Montella, E
Morais-Almeida, M
Mortz, CG
Mullol, J
Namazova-Baranova, L
Neffen, H
Nekam, K
Niedoszytko, M
Odemyr, M
O’Hehir, RE
Okamoto, Y
Ollert, M
Palomares, O
Papadopoulos, NG
Panzner, P
Passalacqua, G
Patella, V
Petrovic, M
Pfaar, O
Pham-Thi, N
Plavec, D
Keywords: COVID-19 vaccines
adrenaline
anaphylaxis
older (adults/people)
Aged
Anaphylaxis
COVID-19
COVID-19 Vaccines
Epinephrine
Humans
Male
SARS-CoV-2
Issue Date: 1-Oct-2021
Publisher: Wiley
Citation: Bousquet, J, Agache, I, Blain, H, Jutel, M, Ventura, MT, Worm, M, Del Giacco, S, Benetos, A, Bilo, BM, Czarlewski, W, Abdul Latiff, AH, Al-Ahmad, M, Angier, E, Annesi-Maesano, I, Atanaskovic-Markovic, M, Bachert, C, Barbaud, A, Bedbrook, A, Bennoor, KS, Berghea, EC, Bindslev-Jensen, C, Bonini, S, Bosnic-Anticevich, S, Brockow, K, Brussino, L, Camargos, P, Canonica, GW, Cardona, V, Carreiro-Martins, P, Carriazo, A, Casale, T, Caubet, JC, Cecchi, L, Cherubini, A, Christoff, G, Chu, DK, Cruz, AA, Dokic, D, De-Yun Wang, El-Gamal, Y, Ebisawa, M, Eberlein, B, Farrell, J, Fernandez-Rivas, M, Fokkens, WJ, Fonseca, JA, Gao, Y, Gavazzi, G, Gawlik, R, Gelincik, A, Gemicioğlu, B, Gotua, M, Guérin, O, Haahtela, T, Hoffmann-Sommergruber, K, Hoffmann, HJ, Hofmann, M, Hrubisko, M, Illario, M, Irani, C, Ispayeva, Z, Ivancevich, JC, Julge, K, Kaidashev, I, Khaitov, M, Knol, E, Kraxner, H, Kuna, P, Kvedariene, V, Lauerma, A, Le, LTT, Le Moing, V, Levin, M, Louis, R, Lourenco, O, Mahler, V, Martin, FC, Matucci, A, Milenkovic, B, Miot, S, Montella, E, Morais-Almeida, M, Mortz, CG, Mullol, J, Namazova-Baranova, L, Neffen, H, Nekam, K, Niedoszytko, M, Odemyr, M, O’Hehir, RE, Okamoto, Y, Ollert, M, Palomares, O, Papadopoulos, NG, Panzner, P, Passalacqua, G, Patella, V, Petrovic, M, Pfaar, O, Pham-Thi, N, Plavec, D (2021-10-01). Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy: European Journal of Allergy and Clinical Immunology 76 (10) : 2952-2964. ScholarBank@NUS Repository. https://doi.org/10.1111/all.14838
Abstract: Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society) Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients.
Source Title: Allergy: European Journal of Allergy and Clinical Immunology
URI: https://scholarbank.nus.edu.sg/handle/10635/227548
ISSN: 01054538
13989995
DOI: 10.1111/all.14838
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Management of anaphylaxis due to COVID-19 vaccines in the elderly.pdf12.33 MBAdobe PDF

OPEN

Post-printView/Download

SCOPUSTM   
Citations

7
checked on Oct 1, 2022

Page view(s)

32
checked on Oct 6, 2022

Download(s)

2
checked on Oct 6, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.